MDXG - MiMedx wins $4.6M contract from US DoD for wound burn care solution

MiMedx Group (NASDAQ:MDXG) has received a $4.6M award from the US Department of Defense to evaluate its Purion processed Dehydrated Human Amnion Chorion Membrane (DHACM) as a treatment option for wound and burn care. The award will be managed and sponsored by the Naval Medical Research Center (NMRC) to advance treatments for combat wounds and burns. MiMedx will use the award to advance the clinical understanding of DHACM as a treatment for acute injuries and to prevent initially partial-thickness burns from deteriorating to life threatening full-thickness burns. MiMedx will also use the data to understand how DHACM can reduce morbidity, limit additional skin grafting, and expedite recovery.

For further details see:

MiMedx wins $4.6M contract from US DoD for wound, burn care solution